Health

The new study conducted by researchers at the Indian Institutes of Science Education and Research (IISER) – Mohali, has now filled the gap. It has shown that a local signaling system defined by two genes called Ultrabithorax (Ubx) and Collier in the tertiary lobe regulated the activities of the progenitors in the tertiary as also secondary lobes and that the system shared several biomarkers with the local environment of the primary lobe.

HIV (Human Immunodeficiency Virus) is a virus that attacks the body’s immune system. HIV causes AIDS (Acquired Immune Deficiency Syndrome) and interferes with the body’s ability to fight infections. About HIV AIDS, it is believed that treatment can provide relief, but this condition cannot be cured. The treatment for HIV is called antiretroviral therapy (ART). ART involves taking a combination of HIV medicines (called an HIV treatment regimen) every day.

In the financial year 2020-21, India Inc. spent over Rs 1,600 crore (US$ 217.02 million) battling the second wave of Covid-19, according to a report released on Monday. According to a research done by CSR information and impact analytics platform ‘CSRBOX’ on over 350 publicly traded businesses, Indian corporations implemented over 750 corporate social responsibility projects in response to the second wave.

Co-WIN has developed a new API called ‘Know Your Customer’s/Client’s Vaccination Status’ or KYC-VS. To use this API, an individual needs to enter his/her mobile number and name. Thereafter, they will get an OTP which they have to enter. In return, Co-WIN will send a response to the verifying entity on the individual’s status of vaccination

Anti-Covid jabs available in India are around 97% effective in preventing mortality, whereas vaccination also significantly reduces hospitalisation, the assessment of real time vaccination data captured under Covid Vaccine tracker shows.

The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in adults of its CORBEVAX™ vaccine against COVID-19 after Subject Expert Committee’s (SEC) review of Phase I and II clinical trials data.

At Prakhar hospital in Kanpur, phase 2 trials of India’s first intranasal vaccine against Covid, which is being developed by Bharat Biotech in conjunction with Washington University School of Medicine in St Louis, have begun.

Continuing its series of activities under the ‘Azadi Ka Amrit Mahotsav’, the Ministry of Ayush launched a campaign of distributing Ayush prophylactic medicines and written guidelines on diet and lifestyle today at New Delhi. The drive was jointly kick-started by Minister of Ayush and Port, Shipping & Waterways Shri Sarbananda Sonowal and Minister of State for Ayush and Woman and Child Development Dr Munjpara Mahendrabhai.